Ebola war.

• Autores: Helen Branswell
• Localización: Scientific American, ISSN 0036-8733, Vol. 312, Nº. 3, 2015, págs. 48-55
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • The article discusses an outbreak of Ebola in West Africa, with a particular emphasis on a pair of experimental vaccines and other new treatments that have been developed. A collaborative effort among Mapp Biopharmaceutical, Kentucky BioProcessing, and others has produced a treatment called ZMapp that targets the Ebola virus. Drug company Merck and biotechnology firm NewLink Genetics are developing an experimental vaccine.